Related Experiment Video
Updated: Jan 30, 2026

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Association between HbA1c and the development of cystic fibrosis-related diabetes
M Choudhury1,2, P Taylor3, P H Morgan4
1All Wales Adult Cystic Fibrosis Centre, University Hospital Llandough, Cardiff, UK.
Insights
Glycated hemoglobin (HbA1c) predicts future cystic fibrosis-related diabetes (CFRD) and retinopathy risk. An HbA1c level of 37 mmol/mol or higher indicates increased risk, aiding in early identification of individuals needing closer monitoring.
Area of Science:
- Endocrinology
- Pulmonology
- Ophthalmology
Background:
- Cystic fibrosis (CF) patients are at increased risk for diabetes.
- Cystic Fibrosis-Related Diabetes (CFRD) diagnosis and management remain challenging.
- Microvascular complications like retinopathy are significant concerns in CFRD.
Purpose of the Study:
- To evaluate Hemoglobin A1c (HbA1c) as a predictive marker for CFRD development.
- To assess the association between HbA1c levels and the incidence of retinopathy in CFRD patients.
Main Methods:
- A 7-year retrospective longitudinal study of 50 adults with CF.
- Comparison of oral glucose tolerance test (OGTT) results with HbA1c values.
- Analysis of retinal screening data against HbA1c measurements.
Main Results:
- An HbA1c ≥37 mmol/mol (5.5%) significantly predicted dysglycemia development (HR 3.49, CI 1.5-8.1).
- Higher HbA1c levels correlated with increased severity of diabetic retinopathy.
- Longer duration of CFRD was also associated with retinopathy severity.
Conclusions:
- HbA1c levels are linked to future dysglycemia and microvascular outcomes in CF patients.
- While not a primary diagnostic tool for CFRD, HbA1c can identify at-risk individuals.
- HbA1c may assist in proactive management and monitoring of CFRD development and complications.
Aims:
To examine HbA1c as a predictor of risk for future development of cystic fibrosis-related diabetes and to assess the association with the development of retinopathy in people with cystic fibrosis-related diabetes.
Methods:
A 7-year retrospective longitudinal study was conducted in 50 adults with cystic fibrosis, comparing oral glucose tolerance test results with HbA1c values in predicting the development of cystic fibrosis-related diabetes. Retinal screening data were also compared with HbA1c measurements to assess microvascular outcome.
Results:
An HbA1c value ≥37 mmol/mol (5.5%; hazard ratio 3.49, CI 1.5-8.1) was significantly associated with the development of dysglycaemia, as defined by the oral glucose tolerance test over a 7-year period. Severity of diabetic retinopathy was associated with a higher HbA1c and longer duration of cystic fibrosis-related diabetes.
Conclusion:
There is a link between HbA1c level and the future development of dysglycaemia in cystic fibrosis based on oral glucose tolerance test, as well as microvascular outcomes. Although current guidance does not advocate the use of HbA1c as a diagnostic tool in cystic fibrosis-related diabetes, it may be of clinical use in determining individuals at risk of future development of cystic fibrosis-related diabetes.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Associative Learning
Classical conditioning, also known...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

